QA: Roivant Sciences Ltd in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001635088_2022_Roivant_Sciences_Ltd.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001635088, Roivant Sciences Ltd

  xvar xval
0 AssetsCurrent 2,186,995,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 14,749,000
3 remainder_Assets 387,948,000
4 LiabilitiesCurrent 218,961,000
5 LiabilitiesNoncurrent 240,833,000
6 remainder_Liabilities 67,893,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 259,878,000
9 ResearchAndDevelopmentExpense 236,626,000
10 remainder_Expenses 599,875,000
11 remainder_Revenues 23,795,000
12 remainder_NetIncome 172,351,000
13 remainder_ComprehensiveNetIncome 94,793,000
  yvar yval
0 Assets 2,589,692,000
1 Liabilities 527,687,000
2 Expenses 1,096,379,000
3 Revenues 23,795,000
4 StockholdersEquity 2,062,005,000
5 NetIncome -900,233,000
6 ComprehensiveNetIncome -852,836,500
7 BaseVar 2,252,348,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.34
9 EconomicCapitalRatio 3.25

Edgar->Model Mapping

Feature Distribution